New ChatGPT Images 2.0 claims a step up in thinking capabilities, detailed instruction following, and improved rendering of ...
The Hillsborough County commissioner said county staff has traced thousands of support emails to a single server in Los ...
Monarch Private Capital, (“Monarch”) and Generate Capital, PBC (“Generate”) today announced the closing of a 104 megawatt (MW) energy investment portfolio.
Generac settles construction-site explosion suit for $206M Generac stock spikes on potential for data center products Generac ...
Rendering isn’t always immediate or complete. Learn where no-JavaScript fallbacks still protect critical content, links, and ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Space The AMOC moves closer to collapse, scientists create artificial neurons, the "Iliad" is found inside and Egyptian mummy, and researchers search for treatments for brain-eating amoebas Artificial ...
Claude can now generate visuals when producing a response. (Anthropic) With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...